Thermo Fisher Scientific Inc.
TMO · Healthcare · · USDFahodi Score HOLD Long-term (Investment)
64
/ 100
Technical
75
Trend & RS
92
Momentum
79
Fundamental
78
Macro
24
Liquidity
44
| Component | Score | Weight |
|---|---|---|
| Technical | 75.0 | 10% |
| Trend & RS | 91.9 | 10% |
| Momentum | 79.1 | 5% |
| Fundamental | 77.8 | 40% |
| Macro | 23.8 | 15% |
| Liquidity | 44.1 | 20% |
Trade Setup
| Entry | 672.88 |
| Stop Loss | 631.26 (6.2%) |
| Target 1 (1:1) | 714.50 (+6.2%) |
| Target 2 (2:1) | 756.12 (+12.4%) |
| ATR(14) | 20.81 (3.1%) |
| Risk per Share | 41.62 |
| Reward:Risk | 2:1 |
ATR-based levels. Adjust for support/resistance zones.
Factor Profile
| Factor | Score | Z | Bar |
|---|---|---|---|
| Value | 43.6 | -0.26 | |
| Momentum | 79.1 | +1.16 | |
| Quality | 44.7 | -0.21 | |
| Composite | 55.8 | ||
Quality Scores
Piotroski F-Score
7
/9 —
Strong
✓
✓
✗
✗
✓
✓
✓
✓
✓
1. Positive Net Income
2. Positive Roa
3. Positive Cfo
4. Quality Earnings
5. Lower Leverage
6. Higher Liquidity
7. No Dilution
8. Higher Gross Margin
9. Higher Asset Turnover
Altman Z-Score
Insufficient Data
Valuation vs Peers Overvalued
| Metric | Stock | Sector | vs Peers |
|---|---|---|---|
| P/E Ratio | 36.2 | 22.0 | +64% above |
| P/B Ratio | 4.6 | 4.0 | Above |
| Dividend Yield | 28.0% | 1.5% | Above avg |
Comparing against Healthcare median multiples.
Trading at a premium to sector peers — verify growth justifies premium.
Intrinsic Value (DCF) Significantly Overvalued
Intrinsic Value
316.34
vs
Market Price
686.04
Upside
-53.9%
| Margin of Safety | -116.9% |
| Stage 1 PV (5yr FCF) | 28,177,356,492 |
| Terminal Value PV | 89,030,106,137 |
| Total Enterprise Value | 117,207,462,629 |
Assumptions
| Base FCF | 5,619,984,517 |
| Growth Rate (5yr) | 9.1% |
| Terminal Growth | 2.5% |
| Discount Rate (WACC) | 9.0% |
2-stage DCF: 5yr projected FCF + Gordon Growth terminal value. Estimates only — adjust growth and WACC for your own assumptions.
Position Sizing — Kelly Criterion
4.6%
Recommended Size
42.16%
Full Kelly
21.08%
Half Kelly
5.0%
Max Cap (Moderate)
Kelly inputs derived from quant score 64/100. Estimated win rate 59%, avg win 8.9%, avg loss 3.7%. Position was capped at the moderate risk maximum. This is analytical output, not a recommendation to trade.
RECOVERY
Regime: RECOVERY (40% confidence) — position size reduced 8%
Signal Summary STRONG BUY
3
Bullish Signals
1
Bearish Signals
47.89
RSI(14)
7.855
MACD
Relative Strength (RS) IMPROVING
79
/ 99
RS Rating
O'Neil filter: <80
| RS vs SPY | ↑ RISING (+17.3% vs SPY 3M) |
| RS vs Sector | INLINE (Healthcare) |
| RS New High | Near 3-month high 2d since high |
| Sector Outperformance | -0.5% (3M) |
RS Line — stock / SPY (90 bars)
← older
newer →
RS vs SPY
50-day SMA of RS
IMPROVING:
Gaining momentum — the stock is starting to outperform the market. Watch for RS new high confirmation.
Technical Indicators
| Indicator | Value | Signal |
|---|---|---|
| Rsi | 47.89 | NEUTRAL |
| Macd | 7.855 | BEARISH |
| Ma Cross | 660.27 / 552.2 | GOLDEN CROSS |
| Trend Short | ABOVE SMA50 | |
| Trend Long | ABOVE SMA200 | |
| Bollinger | MIDDLE | |
| Volume | 0.03x | LOW |
Key Levels
| Level | Price |
|---|---|
| 52-Week High | 712.17 |
| Bollinger Upper | 713.56 |
| SMA(200) | 552.2 |
| SMA(50) | 660.27 |
| SMA(20) | 686.07 |
| Current Price | 686.04 |
| Bollinger Lower | 658.57 |
| 52-Week Low | 435.27 |
| ATR(14) | 20.81 |
Advanced Technical Analysis
Click to expand
Wyckoff Phase & Volume Spread Analysis
Wyckoff Phase
MARKUP
Confidence
100%
Acc: 0.0 |
Dist: 0.0 |
Markup: 2.0 |
Markdown: 0.0
Volume Spread Analysis (last 5 bars)
| Date | Signal | Vol | Description |
|---|---|---|---|
| 2026-11-02 | Normal | 0.81x | Normal bar — no special VSA pattern |
| 2026-11-03 | Normal | 0.72x | Normal bar — no special VSA pattern |
| 2026-11-04 | Normal | 1.08x | Normal bar — no special VSA pattern |
| 2026-11-05 | Normal | 1.24x | Normal bar — no special VSA pattern |
| 2026-11-06 | No Supply | 0.03x | Low volume, narrow spread, firm close — no selling pressure |
Ichimoku Cloud NEUTRAL
| Line | Value | Status |
|---|---|---|
| Tenkan-sen (9) | 686.88 | Above Kijun |
| Kijun-sen (26) | 673.75 | Base line |
| Senkou A | 680.32 | Leading span A |
| Senkou B | 653.27 | Leading span B |
| Cloud | 653.27 – 680.32 | Bullish (Green) |
| Price vs Cloud | 672.88 | Inside Cloud |
| Chikou Span | 654.80 | Bullish |
| Alignment Score | 3/4 | NEUTRAL |
TTM Squeeze & Divergences
TTM Squeeze
SQUEEZE ON
2 bars
Momentum:
BEARISH
BB: 658.57 – 713.56 | KC: 654.66 – 717.47
Divergences (last 60 bars)
| Type | Indicator | Bars Ago | Strength |
|---|---|---|---|
| Regular Bearish | RSI | 7 |
Anchored VWAP
VWAP: 581.01
Anchor: 2026-05-18 (52w Low)
ABOVE AVWAP
+15.8%
Heikin-Ashi Trend
WEAKLY BEARISH
Full data via /api/advanced/TMO
Valuation
| Metric | Value |
|---|---|
| Market Cap | 254.19B |
| P/E (TTM) | 36.18 |
| Forward P/E | N/A |
| P/B | 4.64 |
| EPS | 18.96 |
Financial Health
| Metric | Value |
|---|---|
| Revenue Growth | 9.1% |
| Profit Margin | 14.9% |
| ROE | 13.4% |
| Debt/Equity | 75.36 |
| Current Ratio | 1.81 |
| Dividend Yield | 28.0% |
| Payout Ratio | N/A |
| Beta | 0.84 |
Trading Data
686.04
Open
686.04
Day High
686.04
Day Low
153.4K
Volume (0.1x avg)
Price Chart (90 Days)
Candlesticks (green=up, red=down)
SMA 20
SMA 50
Bollinger Bands (upper/lower)
Volume (green=buying, red=selling)